Assignee
HUANG CAI GU
US·1 granted patent·23 pending applications·0 citations·filing 2007–2021
Top patents by PatentIndex Score
24 records- 0154US11083693B1Liposome formulation of vilanterol trifenatateHUANG CAI GU·Filed 2021·Granted Aug 10, 2021·0 cites·12 claims
- 0250US2008038332A1Stable pharmaceutical formulation comprising atorvastatin calciumHUANG CAI GU·Filed 2007·Application pending·0 cites
- 0348US2021393663A1Pharmaceutical formulation containing active metabolites of remdesivir or its analog for inhalationHUANG CAI GU·Filed 2021·Application pending·0 cites
- 0448US2021346288A1Pharmaceutical formulation containing active metabolites of remdesivir for inhalationHUANG CAI GU·Filed 2021·Application pending·0 cites
- 0548US2022031712A1Preparation of a pharmaceutical composition of olodaterol and budesonideHUANG CAI GU·Filed 2021·Application pending·0 cites
- 0647US2021252027A1Pharmaceutical formulation containing remdesivirHUANG CAI GU·Filed 2021·Application pending·0 cites
- 0747US2021220367A1Inhalable formulation of a solution containing glycopyrrolate and olodaterol hydrochlorideHUANG CAI GU·Filed 2021·Application pending·0 cites
- 0847US2021275449A1Inhalable Formulation of a Solution Containing Glycopyrronium BromideHUANG CAI GU·Filed 2021·Application pending·0 cites
- 0947US2021401855A1Pharmaceutical formulation containing combination of m3 antagonist-beta-2 agonist and inhaled corticosteroidsHUANG CAI GU·Filed 2021·Application pending·0 cites
- 1046US2021353650A1Pharmaceutical formulation containing remdesivir and its active metabolites for dry powder inhalationHUANG CAI GU·Filed 2021·Application pending·0 cites
- 1145US2021030868A1Formulation of antibody based drugs for treating lung cancer by inhalationHUANG CAI GU·Filed 2020·Application pending·0 cites
- 1245US2021322309A1Inhalable Formulation of a Solution Containing OlodaterolHUANG CAI GU·Filed 2021·Application pending·0 cites
- 1345US2021386730A1Pharmaceutical formulation containing glycopyrrolate and indacaterol maleateHUANG CAI GU·Filed 2021·Application pending·0 cites
- 1445US2021393521A1Preparation of a pharmaceutical composition of olodaterol, tiotropium bromide and budesonideHUANG CAI GU·Filed 2021·Application pending·0 cites
- 1544US2021322311A1Inhalable Formulation of a Solution Containing Tiotropium Bromide and OlodaterolHUANG CAI GU·Filed 2021·Application pending·0 cites
- 1644US2021322310A1Inhalable Formulation of a Solution Containing Tiotropium BromideHUANG CAI GU·Filed 2021·Application pending·0 cites
- 1743US2021290568A1Inhalable formulation of a solution containing levalbuterol tartrateHUANG CAI GU·Filed 2021·Application pending·0 cites
- 1842US2020375945A1Inhalable formulation of a solution containing indacaterol maleate and glycopyrronium bromideHUANG CAI GU·Filed 2020·Application pending·0 cites
- 1942US2021030978A1Cartridge with single-layer container and its nozzle-shaped cap for nebulization inhalationHUANG CAI GU·Filed 2020·Application pending·0 cites
- 2042US2020405700A1Inhalable formulation of a solution containing formoterol fumarate and aclidinium bromideHUANG CAI GU·Filed 2020·Application pending·0 cites
- 2142US2021205223A1Propellant-free formulation for inhalationHUANG CAI GU·Filed 2020·Application pending·0 cites
- 2240US2020324064A1Inhalation Device for Administering Powdered Pharmaceutical CompositionHUANG CAI GU·Filed 2020·Application pending·0 cites
- 2339US2021403568A1Biopharmaceutical formulation of anti-pd-1, anti-pd-l1, and anti-vegfr therapeutic monoclonal antibodies and method for treating nsclc by inhalationHUANG CAI GU·Filed 2021·Application pending·0 cites
- 2433US2018344956A1Inhaler Device for Administering Powered Pharmaceutical Compositions via InhalationHUANG CAI GU·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HUANG CAI GU files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →